Leukaemia antigens and immunity in man.
D000818:Animals; D000906:Antibodies / Q000032:analysis; D000917:Antibody Formation; D000951:Antigens, Neoplasm / Q000032:analysis; D002471:Cell Transformation, Neoplastic; D003429:Cross Reactions; D004622:Embryo, Mammalian / Q000276:immunology; D000939:Epitopes; D006649:Histocompatibility Antigens; D006801:Humans; D007106:Immune Sera; D007108:Immune Tolerance; D007111:Immunity, Cellular; D007158:Immunologic Techniques; D007167:Immunotherapy; D007519:Isoantigens; D007938:Leukemia / Q000276:immunology* / Q000628:therapy; D007945:Leukemia, Lymphoid / Q000276:immunology; D007951:Leukemia, Myeloid / Q000276:immunology; D015470:Leukemia, Myeloid, Acute / Q000276:immunology; D008213:Lymphocyte Activation; D011817:Rabbits / Q000276:immunology; D012190:Retroviridae / Q000276:immunology
D000906:Antibodies; D000951:Antigens, Neoplasm; D000939:Epitopes; D006649:Histocompatibility Antigens; D007106:Immune Sera; D007519:Isoantigens